February 3, 2026 · Form 4 insider transaction
Schoenberg Mark sold 1,844 shares of UROGEN PHARMA LTD at $19.69 per share, a transaction worth $36.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.